Rehabilitation of the Adolescent with a Substance Use Disorder: Overview of Treatment Efficacy

Maurizio Pompili^1*, Paola Venturini¹, Dorian A. Lamis², Rachel N. Waford², Denise Erbuto¹, Gianluca Serafini³, Mario Amore³, Paolo Girardi¹

¹Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Italy

²Department of Psychiatry and Behavioural Sciences, Emory University School of Medicine, Atlanta, GA, USA

³Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Psychiatry, University of Genoa, Genoa, Italy

*Corresponding Author:

E-mail: maurizio.pompili@uniroma1.it

Visit for more related articles at International Journal of Emergency Mental Health and Human Resilience

Abstract

Background: Several studies have shown that substance use disorder (SUD) among adolescents is related to multiple behavioural problems and needs specific treatment compared to adults.

Objectives: The aim of the present paper was to investigate the gold standard of rehabilitation efficacy for SUD in adolescence.

Methods: A careful systematic review of the literature was conducted on the treatment and rehabilitation of adolescents with SUD. A total of 11 articles from peer-reviewed journals were selected for this review.

Results: Family therapy is the treatment with the strongest evidence of effectiveness for reducing SUDs in adolescents, although other types of treatments appear to be beneficial such as cognitive-behavioural therapy and other psychological approaches. Despite the effectiveness of the treatments, the rate of relapse remains high among adolescents with SUD.

Conclusion: Currently, psychological treatments, particularly family therapy, are most frequently applied to adolescents with SUD. Pharmacotherapy is reserved for adolescents with a SUD in co-morbidity with other mental disorders and a therapeutic community is suggested for these at-risk adolescents.

INTRODUCTION

Drug use among adolescents represents an important public health problem all over the world. It has been estimated that 1.5 million teenagers meet criteria for at least one substance use disorder (SUDs) (Office of Applied Studies, 2006). Among this population, substances most widely used are alcohol and marijuana/hashish (Hser et al., 2001). The impact of SUDs among youth is very serious considering that SUDs in adolescence is correlated with other significant problems with lifelong implications, including criminal involvement (Rockholz, 2011), physical, sexual and emotional abuse (Hoffman, Abrantes, Anton & Kingston, 2004), academic failure, poly-drug use, mental disorders (Hser et al., 2001), and driving under the influence of drugs (SAMHSA, 2004).

Adolescents have additional vulnerabilities due to their developmental stage. For instance, it has been demonstrated that youths may be more easily influenced by their peers given that individuals often engage in more risk-taking behaviour when in peer groups rather than alone, and peer effects on risk-taking behaviour was higher among adolescents (13-16 years) and youths (18-22 years) than adults (24 years and older) (Gardner & Steinberg, 2005). Moreover, adolescents have higher rates of binge use and psychiatric comorbidity, less awareness of their SUDs (Brown, Anderson, Ramo & Tomlinson, 2005), develop greater cognitive and emotional problems related to the drug use, and have a lower tolerance and experience more adverse effects to drugs due to their developmental stage (Winters, 1999; Brown, Tapert, Granholm & Delis, 2000). An explanation for these differences may be due to the immaturity of the adolescent brain in which the development of cerebral structures that control impulsivity and reasoning and judgment, such as the prefrontal cortex and the nucleus accumbens, are not yet completely formed (Winters, 2004).

The need to investigate specific treatments for SUDs in adolescence is warranted given that this population significantly differs from adults with the same disorder as adolescents not only experience multiple changes during development, but they may also need habilitation and not rehabilitation as well as a parental consent in order to be treated (Winters, 1999), and thus require a different treatment approach. Although the need to develop specific treatment approaches for adolescents with SUDs has been acknowledged since the 1950s, adults and adolescents were treated in the same way until the 1980s when research on this topic was initiated (White, Dennis & Tims, 2002). Therefore, given the public health impact of adolescent SUDs and the relatively recent growing body of research on this issue, the aim of the present review was to evaluate SUDs treatment efficacy in adolescence. We also provide an overview with regards to the relapse rates after treatment.

METHODS

We conducted a Medline and PsycInfo search using the following keywords: “rehabilitation” Or “treatment” And “adolescence” Or “youth” And “Substance Use disorder” specifying all the following names of substances: cocaine, marijuana, hashish, LSD, hallucinogens, amphetamines, phencyclidine, heroine, opiates. We selected only English articles focused on the treatment of adolescents with SUDs that provided specific outcome measures. All the articles (11) are summarized in Table 1. We also collected reviews and meta-analyses published from January 2010 to December 2014 on this topic. The most common outcome measures indicated in the clinical trials were: level of drug use (i.e. abstinence, minor lapse, and relapse) measured by urinalysis, structured and semi-structured interviews, legal and other behavioural problems, school performance, psychological adjustment, and treatment response and recovery.

Table 1: Most relevant studies providing specific outcome measures concerning the treatment of adolescents with SUD.

By reviewing selected articles we identified some specific fields of interest, including effectiveness for all treatment approaches according to different levels of care, levels of SUDs severity, and predictors and factors related to relapse rates. We also consulted a number of international experts in the field to determine whether studies selected were relevant for discussing the topic of this paper. The authors and experts consulted performed a careful analysis of the literature data and agreed on a number of key participants relevant to the aim of this paper. These are outlined in the sections below.

TREATMENT APPROACHES

In accordance with the American Society of Addiction Medicine patient placement criteria, Winters, Botzet & Fahnhorst (2011) summarized the treatment approaches into different levels of care. For all of these levels of care, the psychological approaches utilized can be summarized as follows: psychological approaches that include family therapy, cognitive-behavioural therapy (CBT), motivational enhancement therapy (MET), psychoeducation therapy (PET), contingency management (CM), twelve-step programs, therapeutic community (TC), and pharmacotherapy.

We present our results below regarding the efficacy for all therapeutic models addressing SUDs in adolescence.

TREATMENT EFFICACY

Twelve-Step Programs of Alcoholics Anonymous

We selected several studies focusing on specific kinds of outpatient and inpatient treatment for adolescents with SUDs. Two studies included in this review investigated the efficacy of twelve-step programs among these patients (Winters et al., 2000; Kelly, Dow, Yeterian & Kahler, 2010). Although this treatment approach is based on the tenets of one of the most common therapeutic interventions for SUDs in the United States (Hoffmann, Mee-Lee & Arrowhead, 1993), Alcoholics Anonymous (AA), only 2.3% of the participants are under the age of 21 (Anonymous, 2007,2008). In both studies, the 12-step program was found to be efficacious in reducing drug abuse in adolescence among outpatients and inpatients (Winters et al., 2000; Kelly, Dow, Yeterian & Kahler, 2010). Interestingly, a significant and independent effect of AA/NA (Narcotics Anonymous) attendance on percent days abstinent was found, and was persistent after controlling for the effects of baseline percent days abstinent, prior outpatient/inpatient treatment and prior AA/NA participation, drug abstinence and drug abstinence goal, self-efficacy, and concurrent outpatient treatment session (Kelly, Dow, Yeterian & Kahler, 2010). The authors (Kelly, Dow, Yeterian & Kahler, 2010) also observed that participation in the program was less common among adolescent outpatients with less severe SUDs, as assessed using the Timeline Follow-Back (Sobell & Sobell, 1992), Form-90 (Miller & Del Boca, 1994), and substance use and treatment experiences in the past 90 days.

Cognitive-Behavioural Therapy and Motivational Enhancement Therapy

CBT is a promising therapeutic approach for young people with SUDs. CBT is based on the premise that thoughts influence behaviours and there are multiple ways to perceive and react to stressful environments (Beck & Weishaar, 2005). In the context of SUDs treatment, the goal of CBT is to change the adolescent’s beliefs that contribute to drug use (Galanter, Glickman & Singer, 2007). We reviewed five studies that evaluated the efficacy of CBT by comparing it to family therapy (Hendriks, van der Schee & Blanken, 2011; Waldron et al., 2001), PET (Kaminer, Burleson & Goldberger, 2002), and interactional treatment (Kaminer & Burleson, 1999). In an addiction study, the authors investigated the effectiveness and cost-effectiveness of combination motivational enhancement therapy (MET) and CBT with and without Assertive Continuing Care (ACC) (Godley et al., 2010). In all studies, CBT was considered effective in reducing drug abuse, delinquent behaviours (Hendriks, van der Schee & Blanken, 2011), and improved family function and psychiatric status (Kaminer & Burleson, 1999), particularly when combined with family therapy (Waldron et al., 2001) or with MET (Godley et al., 2010). It has also been found that CBT is superior to PET in older youth and males, but only in the short term (Kaminer, Burleson & Goldberger, 2002). Poorer outcomes for CBT were observed for adolescents with concomitant conduct disorder (Kaminer, Burleson & Goldberger, 2002). Finally, in a recent review, Waldron and Kaminer (Waldron & Kaminer, 2004) suggested that both group and individual CBT are associated with clinically significant reductions in adolescent substance use. Motivational enhancement therapy (MET) is a brief intervention in which the adolescent is invited to reflect on possible risks of his/her abuse and encouraged to develop new strategies for his/her lifestyle with respect to the youth’s freedom of choice (Rollnick & Miller, 1995).

Behavioural Approaches

Contingency management (CM) is a procedure that reinforces positive behaviour change. It focuses on the notion that reinforced behaviours are more likely to reoccur; whereas, punished ones do not. Of the two studies on CM evaluated in this study, one found that CM, coupled with CBT, MET and family therapy, significantly reduced drug abuse among adolescents with SUDs (Carroll et al., 2006). The second study reviewed here concluded that CM was not an effective adjunct to standard community substance abuse treatment in adolescents with marijuana use disorders due to difficulty integrating into outpatient community substance abuse treatment programs (Killeen et al., 2012), as the CM method, although effective when packaged with some manual-based psychosocial treatments, is not associated with adjunctive benefits in standard community substance abuse treatment among adolescents with marijuana use disorder.

Family Therapy

Family therapy is widely utilized in the treatment of SUDs because of its theoretical approach suggesting that family and social relationships play an important role in the development and maintenance of SUDs (Copello, 2002). Four clinical trials included in this review evaluated the effectiveness of family therapy (Hser et al., 2001; Hendriks, van der Schee & Blanken, 2011; Waldron et al., 2001; Santisteban, Maite & Brian, 2011). All of these trials demonstrated that family therapy reduced drug use in patients involved in residential treatment programs (Hser et al., 2001). In a randomized clinical trial evaluating individual CBT, family therapy, combined individual and family therapy, and a group intervention in a sample of 114 substance-abusing adolescents, Waldron et al. (2001) reported significantly fewer days of use in participants who were treated with 4-month family therapy alone, and the combined interventions as well as reductions in percentage of days of use in those who underwent 7 months of combined and group interventions. However, in another randomized controlled trial of 109 adolescents with SUDs, it was found that family therapy was not superior to CBT on the main outcome measures (e.g., cannabis use, delinquent behaviour, treatment response and recovery at one-year follow-up, and treatment intensity and retention) (Hendriks, van der Schee & Blanken, 2011). Specifically, after 12 months, treatment intensity and retention were significantly higher with family therapy than with CBT. These results are in accord with previous findings which have highlighted the important role of family therapy for SUDs among adolescents (Liddle, 2004). Finally, a meta-analytic study examining the effects of outpatient treatment on substance use outcomes for adolescents with substance use disorders revealed that family therapy demonstrated the strongest evidence of comparative effectiveness when compared with group/mixed counselling, CBT, MET, and PET (Tanner-Smith, Wilson & Lipsey, 2013).

Therapeutic Community, Residential, and Assertive Continuing Care Programs

Residential substance use treatment programs are generally brief and limited interventions (e.g., 20 days) (SAMHSA, 2006). Therefore, adolescents with a severe SUDs and psychiatric comorbidity often benefit from long-term treatment away from home in a therapeutic community (TC). It has been shown that a TC is a potentially effective intervention in reducing substance use, criminality and unemployment experienced by addicted individuals (De Leon , 2004). Multiple large-scale studies (Simpson & Sells, 2002; Simpson, Joe & Brown, 1997; Hubbard et al., 1989) reported significant and persistent improvements after successful completion of a TC, in particular after 6–12 months following the residential treatment (Hubbard et al., 1997).

In a TC, adolescents are treated with different approaches such as individual or group counselling, 12-step program, PET, family therapy and CBT with the aim of reintegrating the young patients back into society, particularly those who have been involved with the criminal justice system. Patients in TC differ significantly from their outpatient counterparts in terms of severity of SUDs. They are usually older, with more psychiatric comorbidities and criminal problems, lower levels of education (Rounds-Bryant, Kristiansen & Hubbard, 1999), and are more likely to have a lifetime history of victimization (Shane et al., 2006). Moreover these patients usually fail to complete the residential program, particularly those with commercial health insurance, family history of SUDs and living with only one biological parent (Neumann et al., 2010).

In many treatment systems, adolescents who were admitted to residential treatment typically have the most severe alcohol or other SUDs and were at high risk of relapse. Thus, these individual may have greater difficulty transitioning back to their communities. Assertive Continuing Care (ACC) may be defined as a home-based continuing care approach lasting from 12 to 14 weeks and is mainly designed to increase linkage and retention. ACC demonstrated to be effective in continuing care for adolescents with less severe SUDs ameliorating short-term substance use outcomes (Godley et al., 2002; Godley et al., 2007). ACC has been less effective in outpatient settings (Godley et al., 2010).

Pharmacotherapy

With regard to pharmacotherapy for adolescents with SUDs, the evidence for effectiveness is weak. Bukstein and Cornelius (Bukstein & Cornelius, 2006) posited that this field needs further exploration before any conclusions about efficacy can be drawn. SUDs typically occur around the mid-20s when the maturation of adolescent brain has not been still completely achieved (Casey, Getz & Galvan, 2008; Luna & Sweeney, 2004). In a recent review conducted by Simkin and Grenoble (Simkin & Grenoble, 2010), the authors suggested that there is a paucity of research about pharmacotherapies for SUDs in adolescence because most participants with substance dependence were not diagnosed until early adulthood (e.g., after the age of 18 years). Changes in both volume and structure as well as individual differences in neural responses to reward may predispose some adolescent participants in this period to take more risks, exposing them to greater risk for negative outcomes (Casey, Getz & Galvan, 2008). Limited knowledge about efficacious pharmacotherapeutic interventions may stem from the fact that pharmacotherapy is usually reserved for adolescents with SUDs and a concomitant psychiatric disorder, particularly conduct disorder (King et al., 2000), and the Food and Drug administration (FDA) has only approved medications for alcohol and opioids dependence in adolescence (Simkin & Grenoble, 2010).

In conclusion, our findings replicated the mentioned results of Tanner-Smith and colleagues who, in their 2013 meta-analysis, established that family therapy is associated with the greatest effectiveness for adolescent outpatients in treatment for SUDs (Tanner-Smith, Wilson & Lipsey, 2013). They also documented that a reduction in substance use was better for marijuana/hashish than for alcohol and other drugs (e.g. heroin and cocaine) and that improvements were lower in males, in cases of high levels of psychiatric co-morbidities, and higher levels of alcohol related problems (Tanner-Smith, Wilson & Lipsey, 2013). However, the same authors stated that any definitive conclusions concerning the general advantages of family therapy cannot be drawn as there were some treatments with which family therapy has not been still compared and others for which there are too few studies to draw reliable findings.

RELAPSE RATES

Despite the fact that studies demonstrated the effectiveness of several kinds of treatments in different settings applied to patients with various levels of severity, relapse rates remain high in adolescents with SUDs. It has been established that 66% of patients relapsed 6 months after treatment, and the majority occurred sooner, within 3 months after the completion of treatment. The most common reasons for relapse were social pressure, negative affect and withdrawal (Cornelius et al., 2003). White and colleagues (White et al., 2004) examined possible predictors of relapse in 59 marijuana dependent adolescents and found that relapse occurred very frequently, especially for young people with SUDs and comorbid depression or ADHD. They also noted that a maternal history of substance abuse decreased the probability of completing treatment; however, the role of paternal abuse on treatment completion was marginal (White et al., 2004). Neuman and colleagues found that a family history of substance and/or alcohol abuse was associated with failure to complete treatment among SUDs adolescents (Neumann et al., 2010).

Strategies to avoid relapse include active aftercare, interchangeably mentioned as continuing care, (McKay, 2005; Scott, Foss & Dennis, 2005) as highlighted by Kaminer, Burleson & Burke (2008) who investigated the relation between active aftercare and relapse in adolescents treated for alcohol use disorders. Specifically, Continuing Care may be defined as: “the provision of a treatment plan and organizational structure that will ensure that a patient receives whatever kind of care he or she needs at the time. Thus, the continuing care program is flexible and tailored to the shifting needs of the patient’s level of readiness to change” (American Society of Addiction Medicine, 2001). They administered active aftercare to 177 adolescents with alcohol use disorders and demonstrated that active aftercare maintains or improves treatment outcomes by slowing down the expected post-treatment relapse.

In the evaluation of relapse risks in adolescents with SUDs, two variables have been studied: treatment variables and individual variables. The most relevant treatment variables are the status of discharge, the aftercare plan, the relationship with the therapist, and the alliance with the patient (Whitney, Kelly, Myers & Brown, 2002); whereas, the individual variables include psychiatric comorbidity, contact with drug-using peers, poor coping skills, and a lack of family support (Williams & Chang, 2000; Anderson et al., 2007). Anderson and colleagues (Anderson et al., 2007) also found that one of the most important factors that increase the incidence of relapse is the family environment and family history, including family history of alcohol and drug use disorders. Awareness of these individual and treatment factors has implications for SUDs treatment.

LIMITATIONS

The present review should be considered in light of some limitations. Our data did not permit us to carry out a meta-analysis due to the fact that the studies considered in this review assessed patients at different time points and included different measurements, therefore relevant studies may have been inadvertently not included. Although the current review offers an overview on the phenomenon of SUDs among adolescents, the inclusion and exclusion of studies cited in this paper may reflect the authors’ choice, both according to their expertise and the consultations that they engaged in with experts in the field. Moreover, some studies included in this review have several shortcomings. First, small sample sizes in some studies may have reduced the power to detect real effects. Second, interpretation of results may be difficult due to a number of methodological problems (e.g., the heterogeneity of the included studies in terms of different diagnostic criteria, changes related to the treatment of adolescent substance abuse, inclusion of highly selected clinical samples as well as the variability of the different medications which were used over time).

CONCLUSIONS

Adolescents with SUDs should be considered a separate group from adults with SUDs due to a number of factors and challenges associated with the developmental stage. Different therapies have been investigated showing the general efficacy of treatment when compared to no treatment. Also, psychological approaches, such as family therapy, behavioural therapy, CBT, and motivational enhancement therapy/motivational interviewing resulted among the treatment types associated with the most relevant substance use reductions. Family therapy and social support reduces the development and maintenance of SUDs. Consideration should also be given to other co-morbid diagnoses and specific needs related to adolescent development as this stage is vulnerable to the development of multiple behaviour problems than can persist without intervention. Given the high rates of relapse after treatment, it is important to evaluate a careful strategy even following treatment discharge. In this field, active aftercare approaches appear critical in reducing relapses. Special attention should be paid to the family and social environment of these youths in order to treat SUDs as well as to reduce the risk of relapses in this at-risk population.

References

1. American Society of Addiction Medicine (2001). Patient Placement Criteria for Treatment of Substance Related Disorders, Inc: American Society of Addiction Medicine (Chevy, C.)
2. Anderson, K.G., Ramo, D.E., Schulte, M.T., Cummins, K., & Brown, S.A. (2007). Substance use treatment outcomes for youth: integrating personal and environmental predictors. Drug Alcohol Dependence, 88, 42-48
3. Anonymous, A. (2008). Membership Survey. Available from:
5. Beck, A., Weishaar, M. (2005) Cognitive therapy. In: Corsini, R.J., Wedding, D., (Eds.). Current Psychotherapies, Belmont, CA: Thomson Brooks/Cole Publishing. 7, 238-268
6. Brown, S.A., Anderson, K.G., Ramo, D.E., & Tomlinson, K.L. (2005) Treatment of adolescent alcohol-related problems. A translational perspective. Recent Developments in Alcoholism, 17, 327–348
7. Brown, S.A., Tapert, S.F., Granholm, E., & Delis, D.C. (2000). Neurocognitive functioning of adolescents: Effects of protracted alcohol use. Alcoholism Clinical and Experimental Research. 24, 164-171
8. Bukstein, O.G., & Cornelius, J.R. (2006). Psychopharmacology of adolescents with substance use disorders: using diagnostic-specific treatments. In: Adolescent Substance Abuse: Research and Clinical Advances (Liddle, H.A., Rowe, C.L., Eds.) New York, NY: Cambridge University Press, 241-263
9. Carroll, K.M., Easton, C.J., Nich, C., Hunkele, K.A., Neavins, T.M., Sinha, R., et al. (2006) The use of contingency management and motivational/skills building therapy to treat young adults with marijuana dependence. Journal of Consulting and Clinical Psychology, 74, 955-966
10. Casey, B.J., Getz, S., & Galvan, A. (2008). The adolescent brain. Dev Rev 2008, 28(1), 62-77
11. Copello, A., Orford, J. (2002). Addiction and the family: is it time for services to take notice of the evidence? Addiction, 97,1361-1363
12. Cornelius, J.R, Maisto, S.A., Pollock, N.K., Martin, C.S., Salloum, I.M., Lynch, K.G., et al. (2003). Rapid relapse generally follows treatment for substance use disorders among adolescents. Addictive Behaviors, 28, 381-386
13. De Leon, G. (2004). Therapeutic communities. In: The American Psychiatric Publishing Textbook of Substance Abuse Treatment Galanter (M., Kleber, H., Eds.), Washington, DC: American Psychiatric Publishing, pp.485-501
14. Galanter, M., Glickman, L., & Singer, D. (2007). An overview of outpatient treatment of adolescent substance abuse. Substance abuse, 28, 51-58
15. Gardner, M., & Steinberg, L. (2005). Peer influence on risk taking, risk preference, and risky decision making in adolescence and adulthood: an experimental study. Developmental Psychology, 41, 625-635
16. Godley, M., Godley, S., Dennis, M., Funk, R., & Passetti, L. (2007). The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction, 102, 81
17. Godley, M.D., Godley, S.H., Dennis, M.L., Funk, R., & Passetti, L.L. (2002). Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. Journal of Substance Abuse Treatment,23(1), 21-32
18. Godley, S.H., Garner, B.R., Passetti, L.L., Funk, R.R., Dennis, M.L., & Godley, M.D. (2010). Adolescent outpatient treatment and continuing care: main findings from a randomized clinical trial. Drug Alcohol Depend, 1, 44-54
19. Hendriks, V., van der Schee, E., & Blanken, P. (2011). Treatment of adolescents with a cannabis use disorder: main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug Alcohol Dependence, 1, 64-71
20. Hoffman, N.G., Abrantes, A.M., Anton, R., & Kingston, N.J. (2004). Problems identified by the practical adolescent dual diagnosis interview (PADDI) in a juvenile detention center population. Civic Research Institute. Available from: http://www.civivresearchinstitute.com/achsa/toc_pdfs/TOA_Frontmatter.prf
21. Hoffmann, N., Mee-Lee, D., & Arrowhead, A. (1993). Treatment issues in adolescent substance abuse and addictions: options, outcome, effectiveness, reimbursement, and admission criteria. Adolescent Medicine: State of the Art Reviews, 4, 371–390
22. Hser, Y.I., Grella, C.E., Hubbard, R.L., Hsieh, S.C., Fletcher, B.W., Brown, B.S. et al. (2001). An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry, 58, 689-695
23. http: //www. imap.williamwhitepapers.com/pr/2002HistoryofAdolescentTreatment.pdf
24. Hubbard, R.L., Craddock, S.G., Flynn, P.M., Anderson, J., & Etheridge, R.M. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 261-278
25. Hubbard, R.L., Marsden, M.E., Rachal, J.V., Harwood, H.J., Cavanaugh, E.R., & Ginzburg, H.M. (1989). Drug abuse treatment: A national study of effectiveness. Chapel Hill, NC: University of North Carolina Press
26. Kaminer, Y., & Burleson, J.A. (1999). Psychotherapies for adolescent substance abusers: 15-month follow-up of a pilot study. American Journal on Addictions, 8, 114-119
27. Kaminer, Y., Burleson, J.A., & Burke, R.H. (2008). The Efficacy of Aftercare for Adolescents with Alcohol Use Disorders: A Randomized Controlled Study. Journal of the American Academy of Child & Adolescent Psychiatry, 47, 1405–1412
28. Kaminer, Y., Burleson, J.A., & Goldberger, R. (2002). Cognitive-behavioral coping skills and psychoeducation therapies for adolescent substance abuse. Journal of nervous and mental disease, 190, 737-745
29. Kelly, J.F., Dow, S.J., Yeterian, J.D., & Kahler, C.W. (2010). Can 12-step group participation strengthen an extend the benefits of adolescent addiction treatment? A prospective analysis. Drug and Alcohol Dependence, 110, 117-125
30. Killeen, T.K., McRae-Clark, A.L., Waldrop, A.E., Upadhyaya, H., & Brady, K.T. (2012). Contingency management in community programs treating adolescent substance abuse: a feasibility study. Journal of Child and Adolescent Psychiatric Nursing, 25, 33-41
31. King, R.D., Gaines, L.S., Lambert, E.W., Summerfelt, W.T., & Bickman, L. (2000). The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. Journal of Behavioral Health Services & Research, 27, 417-430
32. Liddle, H.A. (2004). Family-based therapies for adolescent alcohol and drug use: research contributions and future research needs. Addiction, 99, 76-92
33. Luna, B., & Sweeney, J.A. (2004). The emergence of collaborative brain function: FMRI studies of the development of response inhibition. Annals of the New York Academy of Sciences, 1021, 296-309
34. McKay, J.R. (2005). Is there a case for extended interventions for alcohol and drug use disorders? Addiction, 100,1594-1610
35. Miller, W., & Del Boca, F. (1994). Measurement of drinking behavior using the Form 90 family of instruments.Journal of the studies on alcohol and drugs. Supplement.12, 112-118
36. Neumann, A., Ojong, T.N., Yanes, P.K., Tumiel-Berhalter, L., Daigler, G.E., & Blondell, R.D. (2010). Differences between adolescents who complete and fail to complete residential substance abuse treatment. Journal of addictive diseases, 29, 427-435
37. Office of Applied Studies (2006). The NSDUH Report: Substance use treatment need among adolescents: 2003-2004. Rockville, MD: Substance Abuse and Mental Health Services Administration. Available from: http: //www.oas.samhsa.gov/2k6/youthTXneed/youthTXneed.cfm
38. Rockholz, P.B. (2011). Management of youth with substance use disorders in the juvenile justice system. In: Clinical manual of adolescent substance abuse treatments (Kaminer, Y., Winters, K.C., Eds.) Arlington: American Psychiatric, pp. 415-449
39. Rollnick, S., Miller, W.R. (1995). What is motivational interviewing? Behavioural and Cognitive Psychotherapy, 23, 325–334. Available from: http://www.motivationalinterview.net/clinical/whatismi.html
40. Rounds-Bryant, J.L., Kristiansen, P.L., & Hubbard, R.L. (1999). Drug abuse treatment outcome study of adolescents: a comparison of client characteristics and pretreatment behaviors in three treatment modalities. American Journal of Drug and Alcohol Abuse, 25, 573-591
41. Santisteban, D.A., Maite P.M., & Brian E.M. (2011). Preliminary Results for an Adaptive Family Treatment for Drug Abuse in Hispanic Youth. Journal of Family Psychology, 25, 610-614
42. Scott, C.K., Foss, M.A., & Dennis, M.L. (2005). Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery. Drug Alcohol Depression, 78, 325-338
43. Shane, P., Diamond, G.S., Mensinger, J.L., Shera, D., & Wintersteen, M.B. (2006). Impact of victimization on substance abuse treatment outcomes for adolescents in outpatient and residential substance abuse treatment. American Academy of Addiction Psychiatry, 15(1), 34-42
44. Simkin, D.R., & Grenoble, S. (2010). Pharmacotherapies for adolescent substance use disorders. Child and Adolescent Psychiatric Clinics of North America, 19(3), 591-608
45. Simpson, D.D., & Sells, S.B. (2002). Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in alcohol & substance abuse, 2, 7-29
46. Simpson, D.D., Joe, G.W., & Brown, B.S. (1997). Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11, 294-307
48. Sobell, L., & Sobell, M. (1992). Timeline follow-back: A technique for assessing self-reported alcohol consumption. Measuring alcohol consumption: Psychosocial and biochemical methods. Totowa, NJ, US: Humana Press, 41: 72
49. Substance Abuse and Mental Health Services Administration Treatment episode Data Set (TEDS) 2003: Discharges from substance abuse treatment services, 2006
50. Substance Abuse Mental Health Service Administration (2004). Results from the 2003 National Survey on Drug Use and Health: National Findings. Rockville, MD. Available from: http: //www.samhsa.gov/data/nhsda/2k3nsduh/2k3ResultsW.pdf
51. Tanner-Smith, E.E., Wilson, S.J., & Lipsey, M.W. (2013). The comparative effectiveness of outpatient treatment for adolescent substance abuse: a meta-analysis. The Journal of Substance Abuse Treatment, 44, 145-158
52. URL: http://www.aa.org/pdf/products/p-48_07survey.pdf
53. Waldron, H.B., Kaminer, Y. (2004). On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction, 99(2), 93-105
54. Waldron, H.B., Slesnick, N., Brody, J.L., Turner, C.W., & Peterson, T.R. (2001). Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. Journal of Consulting and Clinical Psychology, 69, 802-813
55. White, A.M., Jordan, J.D., Schroeder, K.M., Acheson, S.K., Georgi, B.D., Sauls, G., et al. (2004). Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Journal of Substance Abuse Treatment, 25, 53-59
56. White, W., Dennis, M., & Tims, F.M. (2003). Adolescent treatment: its history and current renaissance. Counselor Magazine, 3, 20-25. Available from:
57. Whitney, S.D., Kelly, J.F., Myers, M.G., & Brown, S.A. (2002). Parental substance use, family support outcome following treatment for adolescent psychoactive substance use disorders. Journal of Child and Adolescent Substance Abuse, 11, 67-81
58. Williams, R., & Chang, S. (2000). A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clinical Psychology: Science and Practice, 7, 138-166
59. Winters, K.C. (1999). DHHS Publication No. (SMA) 99–3283. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment
60. Winters, K.C. (2004). Adolescent brain development and drug use. Treatment Research Institute
61. Winters, K.C., Botzet, A.M., Fahnhorst, T. (2011). Advances in adolescent substance abuse treatment. Current Psychiatry Reports,13, 416-421
62. Winters, K.C., Stinchfield, R.D., Opland, E., Weller, C., & Latimer, W.W. (2000). The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers. Addiction, 95, 601-612.